Article

Membrane Association of the Short Transglutaminase Type 2 Splice Variant (TG2-S) Modulates Cisplatin Resistance in a Human Hepatocellular Carcinoma (HepG2) Cell Line

2024-03-27

Abstract excerpt

Hepatocellular carcinoma (HCC) is a heterogeneous malignancy with complex carcinogenesis. Although there has been significant progress in the treatment of HCC over the past decades, drug resistance to chemotherapy remains a major obstacle in its successful management. In this study we were able to reduce chemoresistance in cisplatin-resistant HepG2 cells by either silencing the expression of transglutaminase type...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 905df492-3b13-52ff-90a1-2b44939b238a
DOI: 10.20944/preprints202302.0103.v2

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Membrane Association of the Short Transglutaminase Type 2 Splice Variant (TG2-S) Modulates Cisplatin Resistance in a Human Hepatocellular Carcinoma (HepG2) Cell LineDOI 10.20944/preprints202302.0103.v2Read

Tissue transglutaminase: a new target to reverse cancer drug resistanceSemantic proximity Read

The Role of Transglutaminase 2 in Cancer: An UpdateSemantic proximity Read

Transglutaminase 2 takes center stage as a cancer cell survival factor and therapy targetSemantic proximity Read

Clinical and biological significance of tissue transglutaminase in ovarian carcinoma.Semantic proximity Read

Expression of transglutaminase-2 isoforms in normal human tissues and cancer cell lines: dysregulation of alternative splicing in cancerSemantic proximity Read

Targeting TIME in advanced hepatocellular carcinoma: Mechanisms of drug resistance and treatment strategiesSemantic proximity Read

Transglutaminase 2 is an RNA-binding protein: Experimental verification and characterisation of a novel transglutaminase featureSemantic proximity Read

Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux TransporterSemantic proximity Read

Evidence that GTP-binding domain but not catalytic domain of transglutaminase 2 is essential for epithelial-to-mesenchymal transition in mammary epithelial cells.Semantic proximity Read

Tissue transglutaminase: from biological glue to cell survival cues.Semantic proximity Read

Transglutaminase 2 exacerbates ovarian cancer survival by inactivating GSK3βSemantic proximity Read

Intracellular localization and conformational state of transglutaminase 2: implications for cell death.Semantic proximity Read